2018-09-01
Multicenter Evaluation of the Idylla NRAS-BRAF Mutation Test in Metastatic Colorectal Cancer
Publication
Publication
The Journal of Molecular Diagnostics , Volume 20 - Issue 5 p. 664- 676
Treatment of colorectal cancer (CRC) with monoclonal antibodies against epidermal growth factor receptor requires the assessment of the mutational status of exons 2, 3, and 4 of the NRAS and KRAS oncogenes. Moreover, the mutational status of exon 15 of the BRAF oncogene is a marker of poor prognosis in CRC. The Idylla NRAS-BRAF Mutation Test is a reliable, simple (<2 minutes hands-on time), and quick (<2 hours turnaround time) sample-to-result solution, enabling the detection of clinically relevant mutations in NRAS (18 mutations) and BRAF (5 mutations). A multicenter study was conducted in 14 centers using the Idylla NRAS-BRAF Mutation Test to assess the NRAS and BRAF mutational status of 418 formalin-fixed, paraffin-embedded tissue samples from CRC patients. Results were compared with those obtained earlier by routine reference methods, including next-generation sequencing, pyrosequencing, mass spectrometry–based assays, PCR-based assays, and Sanger sequencing. In case of discordance, additional tests were performed by digital droplet PCR. Overall, after testing confirmation and excluding invalids/errors by design, concordances between the Idylla NRAS-BRAF Mutation Test and the reference test results were found in almost perfect agreement. In conclusion, the Idylla NRAS-BRAF Mutation Test enables the routine detection of all NRAS and BRAF mutations deemed clinically relevant according to the latest clinical guidelines, without necessitating molecular expertise or infrastructure.
| Additional Metadata | |
|---|---|
| doi.org/10.1016/j.jmoldx.2018.05.008, hdl.handle.net/1765/114305 | |
| The Journal of Molecular Diagnostics | |
|
Prieto-Potin, I. (Iván), Montagut, C. (Clara), Bellosillo, B. (Beatriz), Evans, M. (Matthew), Smith, M. (Matthew), Melchior, L. (Linea), … Rojo, F. (Federico). (2018). Multicenter Evaluation of the Idylla NRAS-BRAF Mutation Test in Metastatic Colorectal Cancer. The Journal of Molecular Diagnostics, 20(5), 664–676. doi:10.1016/j.jmoldx.2018.05.008 |
|